Cost-Effectiveness of Golimumab in Ankylosing Spondylitis from the UK Payer Perspective
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-6584
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cost-Effectiveness of Golimumab in Ankylosing Spondylitis from the UK Payer Perspective ; volume:4 ; number:2 ; day:27 ; month:9 ; year:2017 ; pages:427-443 ; date:12.2017
Rheumatology and therapy ; 4, Heft 2 (27.9.2017), 427-443, 12.2017
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Borse, Rebekah H.
- Beteiligte Personen und Organisationen
-
Brown, Chloe
Muszbek, Noemi
Chaudhary, Mohammad Ashraf
Kachroo, Sumesh
SpringerLink (Online service)
- DOI
-
10.1007/s40744-017-0083-1
- URN
-
urn:nbn:de:1111-201801234469
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:04 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Borse, Rebekah H.
- Brown, Chloe
- Muszbek, Noemi
- Chaudhary, Mohammad Ashraf
- Kachroo, Sumesh
- SpringerLink (Online service)
Ähnliche Objekte (12)
Andersson lesion in ankylosing spondylitis
Surgical treatment of ankylosing spondylitis deformity
Secukinumab: A Review in Ankylosing Spondylitis
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
ANKHvariants associated with ankylosing spondylitis: gender differences
Atherosclerosis in Egyptian patients with ankylosing spondylitis
Association between ankylosing spondylitis and m6A methylation
Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis
Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
Correction to: Secukinumab: A Review in Ankylosing Spondylitis
Development of early diagnostic systems for ankylosing spondylitis
Autoimmune inner ear disease associated with ankylosing spondylitis
Andersson lesion in ankylosing spondylitis
Surgical treatment of ankylosing spondylitis deformity
Secukinumab: A Review in Ankylosing Spondylitis
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
ANKHvariants associated with ankylosing spondylitis: gender differences
Atherosclerosis in Egyptian patients with ankylosing spondylitis
Association between ankylosing spondylitis and m6A methylation
Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis
Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
Correction to: Secukinumab: A Review in Ankylosing Spondylitis
Development of early diagnostic systems for ankylosing spondylitis
Autoimmune inner ear disease associated with ankylosing spondylitis
Andersson lesion in ankylosing spondylitis
Surgical treatment of ankylosing spondylitis deformity
Secukinumab: A Review in Ankylosing Spondylitis
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
ANKHvariants associated with ankylosing spondylitis: gender differences
Atherosclerosis in Egyptian patients with ankylosing spondylitis
Association between ankylosing spondylitis and m6A methylation
Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis
Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
Correction to: Secukinumab: A Review in Ankylosing Spondylitis
Development of early diagnostic systems for ankylosing spondylitis